NRC NRC Health (NRC) Q3 FY26 earnings call
NRC Health returned to double-digit top-line growth driven by full-quarter realization from its large enterprise customer implementation and sustained multi-product contract wins. Operating leverage is emerging as upfront capacity investments get absorbed by recurring software revenue, positioning the business for sequential margin gains despite near-term executive transitions.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
NRC operating KPIs by quarter
| KPI | Jun 2026 Q2 FY26 | This call Sep 2026 Q3 FY26 | Change vs prior quarter |
|---|---|---|---|
| Total recurring contract value | $151.9MWe finished the quarter with total recurring contract value of $151.9 million, up 11% year-over-year, reflecting continued strength across our Experience, Market Insights and the Governance Institute portfolios.Source: earnings call transcript | $154MTotal recurring contract value, or TRCV, grew 9% to $154 million, driven by durable customer relationships and strong renewal performance with the new business building on that base.Source: earnings call transcript | +1.4% |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.